<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Wang L</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Insufficient infiltration of CD8&lt;sup>+&lt;/sup> T cells in the tumor microenvironment (TME) critically restricts antitumor immunity and cancer immunotherapy efficacy. The purpose of this study was to identify novel tumor cell-intrinsic regulators of T-cell infiltration and to elucidate their mechanisms of action.&lt;h4>Methods&lt;/h4>We performed a genome-wide Sleeping Beauty transposon mutagenesis screen in murine breast cancer models. Protein-protein interactions were identified by mass spectrometry and validated by co-immunoprecipitation. Gene and protein expression levels were assessed by reverse transcription and quantitative PCR and western blotting. T-cell infiltration and function were evaluated using flow cytometry, immunohistochemistry (IHC), multiplex IHC, and by analy</pubmed_abstract><journal>Journal for immunotherapy of cancer</journal><pagination>e013142</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12853559</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>DUSP22 dephosphorylates LGALS1 to enhance T cell-driven antitumor immunity.</pubmed_title><pmcid>PMC12853559</pmcid><pubmed_authors>Shao F</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhou N</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Deng CX</pubmed_authors><pubmed_authors>Lei H</pubmed_authors><pubmed_authors>Feng Y</pubmed_authors><pubmed_authors>Sun W</pubmed_authors><pubmed_authors>Dai Y</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Miao K</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Pan J</pubmed_authors><pubmed_authors>Luo P</pubmed_authors><pubmed_authors>Hong Y</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Zeng J</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Sun H</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Zhang A</pubmed_authors></additional><is_claimable>false</is_claimable><name>DUSP22 dephosphorylates LGALS1 to enhance T cell-driven antitumor immunity.</name><description>&lt;h4>Background&lt;/h4>Insufficient infiltration of CD8&lt;sup>+&lt;/sup> T cells in the tumor microenvironment (TME) critically restricts antitumor immunity and cancer immunotherapy efficacy. The purpose of this study was to identify novel tumor cell-intrinsic regulators of T-cell infiltration and to elucidate their mechanisms of action.&lt;h4>Methods&lt;/h4>We performed a genome-wide Sleeping Beauty transposon mutagenesis screen in murine breast cancer models. Protein-protein interactions were identified by mass spectrometry and validated by co-immunoprecipitation. Gene and protein expression levels were assessed by reverse transcription and quantitative PCR and western blotting. T-cell infiltration and function were evaluated using flow cytometry, immunohistochemistry (IHC), multiplex IHC, and by analy</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-09T05:45:55.699Z</modification><creation>2026-06-09T03:08:03.057Z</creation></dates><accession>S-EPMC12853559</accession><cross_references><pubmed>41611244</pubmed><doi>10.1136/jitc-2025-013142</doi></cross_references></HashMap>